The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up - Walsh, T; Stanworth, S; Boyd, J; Hope, D; Hemmatapour, S; Burrows, H; Campbell, H; Pizzo, E; Swart, N; Morris, S (Health Technology Assessment, 2017)